Post hoc analysis of Japanese patients from the placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naive, metastatic castration-resistant prostate cancer-updated results.
Jpn J Clin Oncol
; 47(3): 262-264, 2017 Mar 01.
Article
en En
| MEDLINE
| ID: mdl-28003320
Texto completo:
1
Banco de datos:
MEDLINE
Asunto principal:
Feniltiohidantoína
Tipo de estudio:
Clinical_trials
Límite:
Aged
/
Aged80
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Jpn J Clin Oncol
Año:
2017
Tipo del documento:
Article